20 Stocks Moving In Thursday's Pre-Market Session

Gainers

• Zynerba Pharmaceuticals Inc ZYNE gained 88.2 percent to $11.65 after the company reported top line results in ZYN002 open label Phase 2 FAB-C study in children with Fragile X syndrome. The study successfully met the primary endpoint.
• Exa Corp EXA rose 42.4 percent to $24.15 in pre-market trading. Dassault Systèmes announced plans to acquire Exa for $24.25 per share in cash.
• Sky Solar Holdings Ltd (ADR) SKYS shares rose 38 percent to $2.25 in the pre-market trading session. Sky Solar posted net income of $5.2 million in the first half of 2017, versus a net loss of $2.2 million in the year-ago period.
• Aqua Metals Inc AQMS rose 32.2 percent to $8.00 in pre-market trading after gaining 3.95 percent on Wednesday.
• Chiasma Inc CHMA shares rose 10.2 percent to $2.70 in pre-market trading. Chiasma reported that initial patient is randomized in Phase 3 CHIASMA OPTIMAL clinical trial.
• Izea Inc IZEA rose 8.3 percent to $6.40 in pre-market trading after falling 10.73 percent on Wednesday.
• BlackBerry Ltd BBRY shares rose 7.3 percent to $9.90 in pre-market trading after the company reported stronger-than-expected earnings for its second quarter and reported signing of first BlackBerry secure licensing deal.
• Editas Medicine Inc EDIT rose 5.7 percent to $21.06 in pre-market trading after declining 1.82 percent on Wednesday.
• RedHill Biopharma Ltd - ADR RDHL rose 5.1 percent to $9.55 in pre-market trading after dropping 3.91 percent on Wednesday.
• Dr.Reddy's Laboratories Ltd (ADR) RDY rose 4.5 percent to $36.06 in pre-market trading after dropping 3.31 percent on Wednesday.
• Abbott Laboratories ABT rose 4.2 percent to $54.30 in pre-market trading after the company disclosed that the FDA has approved Abbott Freestyle Libre Flash Glucose Monitoring System.
• Rex Energy Corporation REXX rose 3.6 percent to $2.85 in pre-market trading after surging 17.02 percent on Wednesday.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

• DexCom, Inc. DXCM fell 26.6 percent to $49.55 in pre-market trading following the FDA approval of Abbott's Blood Glucose Monitoring Device and analyst downgrades.
• Pier 1 Imports Inc PIR shares fell 9.6 percent to $4.06 in pre-market trading. Pier 1 Imports posted a narrower-than-expected loss for its second quarter. The company’s comparable sales rose 1.8 percent during the quarter.
• ITUS Corp ITUS shares fell 6.7 percent to $4.06 in pre-market trading after dropping 12.83 percent on Wednesday.
• Veritone Inc VERI shares fell 6.4 percent to $43.00 after dipping 30.28 percent on Wednesday.
• Helios and Matheson Analytics Inc HMNY fell 6.1 percent to $8.20 in pre-market trading after declining 5.25 percent on Wednesday.
• Meritor Inc MTOR fell 5.7 percent to $25.10 in pre-market trading after rising 1.03 percent on Wednesday.
• 22nd Century Group Inc XXII shares fell 4.1 percent to $2.60 in pre-market trading after slipping 1.09 percent on Wednesday.
• Rite Aid Corporation RAD fell 3.1 percent to $2.21 in pre-market trading after the company posted downbeat quarterly sales and named Kermit Crawford as President and COO.